Whether you are evaluating an acquisition, predicting the success of a new indication, or estimating the potential of a new market, RG+A’s innovative healthcare industry forecasting methods are designed to provide you with reliable insights – even in the face of uncertainty.
To help our clients truly understand the impact an event or system will have on their franchises and markets, RG+A has developed a standardized set of impact models reflecting market flows and conditions that affect different disease categories and sometimes specific diseases.
In response to the myriad challenges of market access, RG+A has developed innovative approaches that optimize pricing, reimbursement, and contracting strategies for your pharmaceutical, medical device, or biotechnology product – no matter the phase of development or the geography.
RG+A optimizes your brand’s pricing strategy by synthesizing input from multiple stakeholders throughout the decision chain into a single equation that estimates how the world really works.
From early-stage clinical trial design to later-stage product position and messaging optimization, RG+A’s innovative product development and positioning methods drive actionable insights you need to lay the groundwork for success.